2.
Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC
by Caraceni, Augusto, Prof
The lancet oncology, 2012, Vol.13 (2), p.e58-e68
3.
What Percentage of Chronic Nonmalignant Pain Patients Exposed to Chronic Opioid Analgesic Therapy Develop Abuse/Addiction and/or Aberrant Drug-Related Behaviors? A Structured Evide...
by Fishbain, David A.
Pain medicine (Malden, Mass.), 2008, Vol.9 (4), p.444-459
4.
Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update
by Dworkin, Robert H., PhD
Mayo Clinic proceedings, 2010, Vol.85 (3), p.S3-S14
6.
Activation of the Opioidergic Descending Pain Control System Underlies Placebo Analgesia
by Eippert, Falk
Neuron (Cambridge, Mass.), 2009, Vol.63 (4), p.533-543
7.
Quadratus Lumborum Block Versus Transversus Abdominis Plane Block for Postoperative Pain After Cesarean Delivery: A Randomized Controlled Trial
by Blanco, Rafael
Regional anesthesia and pain medicine, 2016, Vol.41 (6), p.757-762
8.
The Effects of Opioids and Opioid Analogs on Animal and Human Endocrine Systems
by Vuong, Cassidy
Endocrine reviews, 2010, Vol.31 (1), p.98-132
9.
Dynorphin Acts as a Neuromodulator to Inhibit Itch in the Dorsal Horn of the Spinal Cord
by Kardon, Adam P
Neuron (Cambridge, Mass.), 2014, Vol.82 (3), p.573-586
10.
Opioid Induced Hyperalgesia
by Yi, Peter
Pain medicine (Malden, Mass.), 2015, Vol.16 (S1), p.S32-S36
11.
Re-energizing the Development of Pain Therapeutics in Light of the Opioid Epidemic
by Skolnick, Phil
Neuron (Cambridge, Mass.), 2016, Vol.92 (2), p.294-297
12.
Placebo Analgesia: A Predictive Coding Perspective
by Büchel, Christian
Neuron (Cambridge, Mass.), 2014, Vol.81 (6), p.1223-1239
13.
Pain Management in the Cirrhotic Patient: The Clinical Challenge
by Chandok, Natasha, MD
Mayo Clinic proceedings, 2010, Vol.85 (5), p.451-458
14.
Cardiac Effects of Opioid Therapy
by Chen, Alexander
Pain medicine (Malden, Mass.), 2015, Vol.16 (S1), p.S27-S31
15.
Causes and Consequences of Inadequate Management of Acute Pain
by Sinatra, Raymond
Pain medicine (Malden, Mass.), 2010, Vol.11 (12), p.1859-1871
16.
Delta/mu opioid receptor interactions in operant conditioning assays of pain-depressed responding and drug-induced rate suppression: assessment of therapeutic index in male Sprague...
by Cone, Katherine
Psychopharmacology, 2018, Vol.235 (5), p.1609-1618
17.
Pain as the Fifth Vital Sign: Exposing the Vital Need for Pain Education
by Morone, Natalia E., MD, MS
Clinical therapeutics, 2013, Vol.35 (11), p.1728-1732
18.
Dissociable effects of the kappa opioid receptor agonist nalfurafine on pain/itch-stimulated and pain/itch-depressed behaviors in male rats
by Lazenka, Matthew L
Psychopharmacology, 2017, Vol.235 (1), p.203-213
19.
The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research
by Henningfield, Jack E
Psychopharmacology, 2017, Vol.235 (2), p.573-589
20.
Deficits in autonomic indices of emotion regulation and reward processing associated with prescription opioid use and misuse
by Garland, Eric L
Psychopharmacology, 2016, Vol.234 (4), p.621-629
